The Pharmacy Times® Asthma Resource Center is a comprehensive resource for clinical news and expert insights on issues related to the treatment of the chronic lung disease, in which the airways narrow and swell.
July 26th 2024
The molecule can be a potential treatment that counters effects of early-life antibiotics, which can impact the gut microbiota and increase the risk of childhood atopy and asthma.
FDA Approves Pre-Filled Pen for Self-Administration of Tezepelumab-ekko to Treat Asthma
February 6th 2023In a clinical trial program, 92% of health care providers, patients, and caregivers were able to successfully administer tezepelumab-ekko both in the clinic and at home for severe asthma.
Read More
Clinical Overview: PT027 for Exacerbation Risk Reduction, Improved Lung Function in Asthma
May 11th 2022The combination of albuterol/budesonide shows promise in lowering the risk of severe exacerbations and improved lung function compared to albuterol as a rescue inhaler in patients with asthma.
Read More